Enhanced healing of rat calvarial defects with sulfated chitosan-coated calcium-deficient hydroxyapatite/bone morphogenetic protein 2 scaffolds

Tissue Engineering - Part A

Volumn 18, Issue 1-2, 2012, Pages 185-197

  Zhao, Jun ^a   Shen, Gang ^a   Liu, Changsheng ^b   Wang, Shaoyi ^a   Zhang, Wenjie ^c   Zhang, Xiaochen ^a   Zhang, Xiuli ^c   Ye, Dongxia ^c   Wei, Jie ^b   Zhang, Zhiyuan ^a   Jiang, Xinquan ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b East China University of Science and Technology   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BONE; BONE CEMENT; CALCIUM PHOSPHATE; CHITOSAN; COATINGS; COMPUTERIZED TOMOGRAPHY; DEFECTS; DEGRADATION; HYDROXYAPATITE; PROTEINS; SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN-2; BONE REGENERATION; CALCIUM DEFICIENT HYDROXYAPATITE; CALCIUM PHOSPHATE CEMENT; CHITOSAN COATINGS; GROWTH FACTOR; GROWTH FACTOR DELIVERY; IN-VITRO; RELEASE PROFILES; SULFATED CHITOSAN;

RATS;

CRANIA; RATTUS;

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; CHITOSAN SULFATE; FLUORESCENT DYE; HYDROXYAPATITE; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; BIOMECHANICS; BONE DEVELOPMENT; BONE MINERALIZATION; BONE REGENERATION; CHEMISTRY; DELAYED RELEASE FORMULATION; DISEASE MODEL; DRUG EFFECT; FISCHER 344 RAT; KINETICS; MALE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; RADIOGRAPHY; RAT; SCANNING ELECTRON MICROSCOPY; SKULL; WOUND HEALING;

ANIMALS; BIOMECHANICS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CALCIFICATION, PHYSIOLOGIC; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; DURAPATITE; FLUORESCENT DYES; KINETICS; MALE; MICROSCOPY, ELECTRON, SCANNING; OSTEOGENESIS; RATS; RATS, INBRED F344; SKULL; TISSUE SCAFFOLDS; WOUND HEALING; X-RAY MICROTOMOGRAPHY;

EID: 84855397191     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0297     Document Type: Article

References (44)

1. Wozney, J.M., and Rosen, V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 346, 26, 1998.
2. Wozney, J.M. Overview of bone morphogenetic proteins. Spine 27, S2, 2002.
3. Bohner, M., Gbureck, U., and Barralet, J.E. Technological issues for the development of more efficient calcium phosphate bone cements: a critical assessment. Biomaterials 26, 6423, 2005.
4. Habraken, W.J., Boerman, O.C., Wolke, J.G., Mikos, A.G., and Jansen, J.A. In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres. J Biomed Mater Res A 91, 614, 2009.
5. Ruhé, P.Q., Boerman, O.C., Russel, F.G., Spauwen, P.H., Mikos, A.G., and Jansen, J.A. Controlled release of rhBMP-2 loaded poly(dl-lactic-co- glycolic acid)/calcium phosphate cement composites in vivo. J Control Release 106, 162, 2005.
6. Ginebra, M.P., Traykova, T., and Planell, J.A. Calcium phosphate cements as bone drug delivery systems: a review. J Control Release 113, 102, 2006.
7. Ruhé, P.Q., Kroese-Deutman, H.C., Wolke, J.G., Spauwen, P.H., and Jansen, J.A. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits. Biomaterials 25, 2123, 2004.
8. Kroese-Deutman, H.C., Ruhé, P.Q., Spauwen, P.H., and Jansen, J.A. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits. Biomaterials 26, 1131, 2005.
9. Wang, L., Zou, D., Zhang, S., Zhao, J., Pan, K., and Huang, Y. Repair of bone defects around dental implants with bone morphogenetic protein/fibroblast growth factor-loaded porous calcium phosphate cement: a pilot study in a canine model. Clin Oral Implants Res 22, 173, 2011.
10. Monteiro, M.M., Campos da Rocha, N.C., Rossi, A.M., and de Almeida Soares, G. Dissolution properties of calcium phosphate granules with different compositions in simulated body fluid. J Biomed Mater Res A 65, 299, 2003.
11. Guo, H., Su, J., Wei, J., Kong, H., and Liu, C. Biocompatibility and osteogenicity of degradable Ca-deficient hydroxyapatite scaffolds from calcium phosphate cement for bone tissue engineering. Acta Biomater 5, 268, 2009.
12. Xu, H.H., Carey, L.E., and Simon, C.G., Jr. Premixed macroporous calcium phosphate cement scaffold. J Mater Sci Mater Med 18, 1345, 2007.
13. Boyne, P.J., Marx, R.E., Nevins, M., Triplett, G., Lazaro, E., Lilly, L.C., Alder, M., and Nummikoski, P. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 17, 11, 1997.
14. Howell, T.H., Fiorellini, J., Jones, A., Alder, M., Nummikoski, P., Lazaro, M., Lilly, L., and Cochran, D. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 17, 124, 1997.
15. Ruhé, P.Q., Boerman, O.C., Russel, F.G., Mikos, A.G., Spauwen, P.H., and Jansen, J.A. In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med 17, 919, 2006.
16. Kempen, D.H., Lu, L., Hefferan, T.E., Creemers, L.B., Maran, A., Classic, K.L., Dhert, W.J., and Yaszemski, M.J. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 29, 3245, 2008.
17. Ruhe, P.Q., Hedberg, E.L., Padron, N.T., Spauwen, P.H., Jansen, J.A., and Mikos, A.G. rhBMP-2 release from injectable poly(dl-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg Am 85A(Suppl 3), 75, 2003.
18. Bodde, E.W., Boerman, O.C., Russel, F.G., Mikos, A.G., Spauwen, P.H., and Jansen, J.A. The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. J Biomed Mater Res A 87, 780, 2008.
19. Li, M., Liu, X., Liu, X., and Ge, B. Calcium phosphate cement with BMP-2-loaded gelatin microspheres enhances bone healing in osteoporosis: a pilot study. Clin Orthop Relat Res 468, 1978, 2010.
20. Luginbuehl, V., Meinel, L., Merkle, H.P., and Gander, B. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 58, 197, 2004.
21. Zhou, H., Qian, J., Wang, J., Yao, W., Liu, C., Chen, J., and Cao, X. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo. Biomaterials 30, 1715, 2009.
22. Ruppert, R., Hoffmann, E., and Sebald, W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 237, 295, 1996.
23. Scheufler, C., Sebald, W., and Hü lsmeyer, M. Crystal structure of human bone morphogenetic protein-2 at 2.7A resolution. J Mol Biol 287, 103, 1999.
24. Green, S., Roldo, M., Douroumis, D., Bouropoulos, N., Lamprou, D., and Fatouros, D.G. Chitosan derivatives alter release profiles of model compounds from calcium phosphate implants. Carbohydr Res 344, 901, 2009.
25. Raman, R., Sasisekharan, V., and Sasisekharan, R. Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem Biol 12, 267, 2005.
26. Yuan, L., Yue, Z., Chen, H., Huang, H., and Zhao, T. Biomacromolecular affinity: interactions between lysozyme and regioselectively sulfated chitosan. Colloids Surf B Biointerfaces 73, 346, 2009.
27. Liu, C., Shao, H., Chen, F., and Zheng, H. Rheological properties of concentrated aqueous injectable calcium phosphate cement slurry. Biomaterials 27, 5003, 2006.
28. Zhang, D., Chu, F., Yang, Y., Xia, L., Zeng, D., Uludag? , H., Zhang, X., Qian, Y., and Jiang, X. Orthodontic tooth movement in alveolar cleft repaired with a tissue engineering bone: an experimental study in dogs. Tissue Eng Part A 17, 1313, 2011.
29. Kasten, P., Vogel, J., Geiger, F., Niemeyer, P., Luginbü hl, R., and Szalay, K. The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29, 3983, 2008.
30. Niemeyer, P., Szalay, K., Luginbü hl, R., Sü dkamp, N.P., and Kasten, P. Transplantation of human mesenchymal stem cells in a non-autogenous setting for bone regeneration in a rabbit critical-size defect model. Acta Biomater 6, 900, 2010.
31. Liu, G., Li, Y., Sun, J., Zhou, H., Zhang, W., Cui, L., and Cao, Y. In vitro and in vivo evaluation of osteogenesis of human umbilical cord blood-derived mesenchymal stem cells on partially demineralized bone matrix. Tissue Eng Part A 16, 971, 2010.
32. Wang, S., Zhang, Z., Zhao, J., Zhang, X., Sun, X., Xia, L., Chang, Q., Ye, D., and Jiang, X. Vertical alveolar ridge augmentation with beta-tricalcium phosphate and autologous osteoblasts in canine mandible. Biomaterials 30, 2489, 2009.
33. Sawyer, A.A., Song, S.J., Susanto, E., Chuan, P., Lam, C.X., Woodruff, M.A., Hutmacher, D.W., and Cool, S.M. The stimulation of healing within a rat calvarial defect by mPCLTCP/collagen scaffolds loaded with rhBMP-2. Biomaterials 30, 2479, 2009.
34. Zolnik, B.S., and Burgess, D.J. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release 122, 338, 2007.
35. Fei, Z., Hu, Y., Wu, D., Wu, H., Lu, R., Bai, J., and Song, H. Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement. J Mater Sci Mater Med 19, 1109, 2008.
36. Matsumoto, T., Okazaki, M., Inoue, M., Yamaguchi, S., Kusunose, T., Toyonaga, T., Hamada, Y., and Takahashi, J. Hydroxyapatite particles as a controlled release carrier of protein. Biomaterials 25, 3807, 2004.
37. Hollinger, J.O., Uludag, H., and Winn, S.R. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev 31, 303, 1998.
38. Abarrategi, A., Moreno-Vicente, C., Ramos, V., Aranaz, I., Sanz Casado, J.V., and López-Lacomba, J.L. Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application. Tissue Eng Part A 14, 1305, 2008.
39. Kundu, B., Lemos, A., Soundrapandian, C., Sen, P.S., Datta, S., Ferreira, J.M., and Basu, D. Development of porous HAp and b-TCP scaffolds by starch consolidation with foaming method and drug-chitosan bilayered scaffold based drug delivery system. J Mater Sci Mater Med 21, 2955, 2010.
40. Kanczler, J.M., and Oreffo, R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15, 100, 2008.
41. Kasten, P., Luginbü hl, R., van Griensven, M., Barkhausen, T., Krettek, C., Bohner, M., and Bosch, U. Comparison of human bone marrow stromal cells seeded on calciumdeficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix. Biomaterials 24, 2593, 2003.
42. LeGeros, RZ. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res 395, 81, 2002.
43. Bruder, S.P., Kraus, K.H., Goldberg, V.M., and Kadiyala, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80, 985, 1998.
44. Tsutsumi, R., Hock, C., Bechtold, C.D., Proulx, S.T., Bukata, S.V., Ito, H., Awad, H.A., Nakamura, T., O'Keefe, R.J., and Schwarz, E.M. Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT. J Orthop Res 26, 1340, 2008.